GKOS
GlaukosCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
The constructive case is that GKOS has already moved Epioxa from approval into commercial launch and secured a permanent J-code effective July 1, 2026, while the March 2026 investor presentation continued to position iDose TR and Epioxa as the company's two major growth drivers [#8-K-2026-03-02]. If Q1 commentary later confirms early launch traction, investors could lean back toward the roughly $134.8 median target in the packet.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.2.
What can break
As of April 29, 2026 UTC, the scheduled Q1 2026 earnings release had not yet been confirmed from checked sources, leaving revenue, EPS, guidance, and market-reaction evidence unavailable for this run.
Momentum
85
Value
37
Sentiment
42
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $130.00 · Bull $145.00 · Bear $105.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $165.00
Why
Momentum85 · Δ7d -3.2
Value37 · Δ7d -0.0
Sentiment42 · Δ7d -4.8
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
85
26% active weight
Current posture
7d trendImproving
Δ7d
-3.2
Δ21d
+13.7
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
42
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.8
Δ21d
-8.4
Why this grade
Composite grade C. Momentum 84.9 / Value 36.5 / Sentiment 42.4
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$9.13B
Beta
0.71
Shares Out
58.73M
P/E (TTM) · Derived
-47.4
P/S (TTM)
13.75
P/FCF (TTM) · Derived
-255.90
Rev YoY
+41.2%
EPS YoY
+6.4%
Gross Margin
+78.1%
Op Margin
-18.8%
Net Debt
-$172.22M
Current Ratio
5.43
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology